{"DataElement":{"publicId":"3444137","version":"1","preferredName":"Gastric Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage","preferredDefinition":"Extent of the primary gastric cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3443884v1.0:3443924v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3443884","version":"1","preferredName":"Gastric Cancer Clinical T Stage","preferredDefinition":"Relating to the stomach._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3443882v1.0:2207100v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3443882","version":"1","preferredName":"Gastric Neoplasm","preferredDefinition":"Relating to the stomach.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C13307:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric","conceptCode":"C13307","definition":"Relating to the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E583-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BE9BBA38-E591-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"TAYLORT","dateModified":"2018-12-04","changeDescription":"12/3/18 tmt transferred context from NCIP. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3443924","version":"1","preferredName":"Gastric Cancer American Joint Committee on Cancer Edition 7 T Stage","preferredDefinition":"A finding about one or more characteristics of gastric cancer, following the rules of the TNM AJCC v7 classification system.  Tumors arising at the esophagogastric junction, or arising in the stomach in a distance equal or less than 5 cm from the esophagogastric junction and crossing the esophagogastric junction are staged using the TNM system for esophageal adenocarcinoma.  Lymphomas, sarcomas, and carcinoid tumors (low-grade neuroendocrine tumors) are not included in this classification. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3443924v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TX","valueDescription":"Gastric Cancer pTX TNM Finding","ValueMeaning":{"publicId":"3443926","version":"1","preferredName":"Gastric Cancer pTX TNM Finding","longName":"3443926","preferredDefinition":"Gastric cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pTX TNM Finding v6 and v7","conceptCode":"C61181","definition":"Gastric cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E742-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9BBA38-E75B-4C0E-E040-BB89AD430CAC","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Gastric Cancer pT4b TNM Finding v7","ValueMeaning":{"publicId":"3443928","version":"1","preferredName":"Gastric Cancer pT4b TNM Finding v7","longName":"3443928","preferredDefinition":"Gastric cancer with tumor invading adjacent structures. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT4b TNM Finding v7","conceptCode":"C89841","definition":"Gastric cancer with tumor invading adjacent structures. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-3559-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-3572-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Gastric Cancer pT4a TNM Finding v7","ValueMeaning":{"publicId":"3443930","version":"1","preferredName":"Gastric Cancer pT4a TNM Finding v7","longName":"3443930","preferredDefinition":"Gastric cancer with tumor invading serosa (visceral peritoneum). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT4a TNM Finding v7","conceptCode":"C89840","definition":"Gastric cancer with tumor invading serosa (visceral peritoneum). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-357F-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-3598-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T4","valueDescription":"Gastric Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"3443932","version":"1","preferredName":"Gastric Cancer pT4 TNM Finding v7","longName":"3443932","preferredDefinition":"Gastric cancer with tumor invading serosa (visceral peritoneum) or adjacent structures.  The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum.  Intramural extension to the duodenum or esophagus is classified by the depth of the greatest invasion in any of these sites, including the stomach. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT4 TNM Finding v7","conceptCode":"C89839","definition":"Gastric cancer with tumor invading serosa (visceral peritoneum) or adjacent structures.  The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum.  Intramural extension to the duodenum or esophagus is classified by the depth of the greatest invasion in any of these sites, including the stomach. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-35A5-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-35BE-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T3","valueDescription":"Gastric Cancer pT3 TNM Finding v7","ValueMeaning":{"publicId":"3443934","version":"1","preferredName":"Gastric Cancer pT3 TNM Finding v7","longName":"3443934","preferredDefinition":"Gastric cancer with tumor penetrating subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum.  Intramural extension to the duodenum or esophagus is classified by the depth of the greatest invasion in any of these sites, including the stomach. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT3 TNM Finding v7","conceptCode":"C89838","definition":"Gastric cancer with tumor penetrating subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum.  Intramural extension to the duodenum or esophagus is classified by the depth of the greatest invasion in any of these sites, including the stomach. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-35CB-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-35E4-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T2","valueDescription":"Gastric Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"3443936","version":"1","preferredName":"Gastric Cancer pT2 TNM Finding v7","longName":"3443936","preferredDefinition":"Gastric cancer with tumor invading the muscularis propria.  A tumor may penetrate the muscularis propria with extension into the gastrocolic or gastrohepatic ligaments, or into the greater or lesser omentum, without perforation of the visceral peritoneum covering these structures. In this case, the tumor is classified T3. If there is perforation of the visceral peritoneum covering the gastric ligaments or the omentum, the tumor should be classified T4. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT2 TNM Finding v7","conceptCode":"C89834","definition":"Gastric cancer with tumor invading the muscularis propria.  A tumor may penetrate the muscularis propria with extension into the gastrocolic or gastrohepatic ligaments, or into the greater or lesser omentum, without perforation of the visceral peritoneum covering these structures. In this case, the tumor is classified T3. If there is perforation of the visceral peritoneum covering the gastric ligaments or the omentum, the tumor should be classified T4. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-35F1-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-360A-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Gastric Cancer pT1b TNM Finding v7","ValueMeaning":{"publicId":"3443938","version":"1","preferredName":"Gastric Cancer pT1b TNM Finding v7","longName":"3443938","preferredDefinition":"Gastric cancer invading the submucosa. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT1b TNM Finding v7","conceptCode":"C89833","definition":"Gastric cancer invading the submucosa. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-3617-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-3630-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Gastric Cancer pT1a TNM Finding v7","ValueMeaning":{"publicId":"3443940","version":"1","preferredName":"Gastric Cancer pT1a TNM Finding v7","longName":"3443940","preferredDefinition":"Gastric cancer with tumor invading lamina propria or muscularis mucosae.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT1a TNM Finding v7","conceptCode":"C89832","definition":"Gastric cancer with tumor invading lamina propria or muscularis mucosae.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-363D-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-3656-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T1","valueDescription":"Gastric Cancer pT1 TNM Finding v7","ValueMeaning":{"publicId":"3443942","version":"1","preferredName":"Gastric Cancer pT1 TNM Finding v7","longName":"3443942","preferredDefinition":"Gastric cancer invading lamina propria, muscularis mucosae, or submucosa. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT1 TNM Finding v7","conceptCode":"C89831","definition":"Gastric cancer invading lamina propria, muscularis mucosae, or submucosa. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-3663-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-367C-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Gastric Cancer pTis TNM Finding","ValueMeaning":{"publicId":"3443944","version":"1","preferredName":"Gastric Cancer pTis TNM Finding","longName":"3443944","preferredDefinition":"Gastric cancer in situ with cancer cells confined within the glandular basement membrane (intraepithelial) and without invasion into the lamina propria. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pTis TNM Finding v6 and v7","conceptCode":"C61183","definition":"Gastric cancer in situ with cancer cells confined within the glandular basement membrane (intraepithelial) and without invasion into the lamina propria. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-3689-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-36A2-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"},{"value":"T0","valueDescription":"Gastric Cancer pT0 TNM Finding","ValueMeaning":{"publicId":"3443946","version":"1","preferredName":"Gastric Cancer pT0 TNM Finding","longName":"3443946","preferredDefinition":"Gastric cancer with no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer pT0 TNM Finding v6 and v7","conceptCode":"C61182","definition":"Gastric cancer with no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9D1DC7-36AF-BF55-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE9D1DC7-36C8-BF55-E040-BB89AD437928","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3443923","version":"1","preferredName":"Gastric Cancer TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A finding about one or more characteristics of gastric cancer, following the rules of the TNM AJCC v7 classification system.  Tumors arising at the esophagogastric junction, or arising in the stomach in a distance equal or less than 5 cm from the esophagogastric junction and crossing the esophagogastric junction are staged using the TNM system for esophageal adenocarcinoma.  Lymphomas, sarcomas, and carcinoid tumors (low-grade neuroendocrine tumors) are not included in this classification. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89822:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer TNM Finding v7","conceptCode":"C89822","definition":"A finding about one or more characteristics of gastric cancer, following the rules of the TNM AJCC v7 classification system.  Tumors arising at the esophagogastric junction, or arising in the stomach in a distance equal or less than 5 cm from the esophagogastric junction and crossing the esophagogastric junction are staged using the TNM system for esophageal adenocarcinoma.  Lymphomas, sarcomas, and carcinoid tumors (low-grade neuroendocrine tumors) are not included in this classification. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E716-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E727-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434444","version":"1","longName":"Stomach (Gastric)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777528","version":"1","longName":"Stomach-Gastric","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BEAB03DB-AE0E-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}